Voyager Therapeutics, Inc. (VYGR:NASDAQ) closed at $2.06 on October 15, 2026, up 2.49% on the day. The stock trades 62.9% below its 52-week high of $5.55 and 3.5% above its 52-week low of $1.99. Over the past year, it lost 62.0%. Voyager Therapeutics, Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -11.45% | -34.95% | -36.59% | -52.48% | -62.00% |
In 252 trading sessions since October 15, 2025, VYGR closed higher on 115 days (46%). Its best day was March 10, 2026 (+21.65%) and its worst was May 15, 2026 (-11.08%). The stock moved 10% or more in a single session 3 times.
Voyager Therapeutics Inc, in collaboration with Genzyme, conducts research and development work to develop therapies for the treatment of central nervous system disorders. It targets diseases such as Parkinson's, Alzheimer's Huntington's.
Find more stocks like VYGR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.